|
Market Cap | 124.80M | EPS (ttm) | -1.07 |
P/E | - | EPS this Y | -508.33% |
Forward P/E | - | EPS next Y | 49.68% |
PEG | - | EPS past 5Y | - |
P/S | 0.31 | EPS next 5Y | - |
P/B | 0.38 | EPS Q/Q | -7986.04% |
Dividend | - | Sales Q/Q | 24.10% |
Insider Own | 30.26% | Inst Own | 71.45% |
Insider Trans | -0.16% | Inst Trans | 32.39% |
Short Float | 17.96% | Earnings | May 09/b |
Analyst Recom | 2.71 | Target Price | 4.08 |
Avg Volume | 3.54M | 52W Range | 1.70 - 28.13 |
|
|
|
Amylyx Pharmaceuticals, Inc. is a commercial-stage biotechnology company, which engages in the provision of therapies for neurodegenerative diseases and amyotrophic lateral sclerosis (ALS). Its commercial product is Relyvrio, also known as Albrioza in Canada. The company was founded by Joshua Cohen and Justin Klee in 2013 and is headquartered in Cambridge, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Quimi Daphne | Director | May 15 '24 | Buy | 1.89 | 2,250 | 4,252 | 5,000 | May 16 07:37 PM | Mazzariello Gina | Chief Legal Officer | May 15 '24 | Sale | 1.88 | 10,455 | 19,654 | 151,477 | May 16 07:36 PM | Quimi Daphne | Director | May 14 '24 | Buy | 1.89 | 2,750 | 5,184 | 2,750 | May 16 07:37 PM | Klee Justin B. | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 2,959,308 | Mar 07 04:05 PM | Cohen Joshua B | Co-Chief Executive Officer | Mar 05 '24 | Sale | 18.73 | 4,135 | 77,440 | 3,023,002 | Mar 07 04:05 PM |
|
|
|
|
Market Cap | 1.89B | EPS (ttm) | 3.28 |
P/E | 19.65 | EPS this Y | 14.14% |
Forward P/E | 15.97 | EPS next Y | 7.97% |
PEG | 1.97 | EPS past 5Y | 4.41% |
P/S | 2.35 | EPS next 5Y | 10.00% |
P/B | 4.63 | EPS Q/Q | 110.77% |
Dividend | - | Sales Q/Q | 2.42% |
Insider Own | 5.92% | Inst Own | 92.33% |
Insider Trans | -44.26% | Inst Trans | -4.06% |
Short Float | 4.03% | Earnings | May 01/b |
Analyst Recom | 1.00 | Target Price | 70.50 |
Avg Volume | 211.28K | 52W Range | 41.98 - 66.21 |
|
|
Today 03:17AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $5,313,639, According to a Recent SEC Filing
(MT Newswires) |
May-14-24 09:30AM
|
Wall Street Analysts Think Donnelley Financial (DFIN) Is a Good Investment: Is It?
(Zacks) |
03:26AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $11,626,694, According to a Recent SEC Filing
(MT Newswires) |
May-13-24 05:14PM
|
Full Video Coverage: Readiness and the Road to IPO Panel from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
05:14PM
|
Video Highlights from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
May-10-24 10:05AM
|
Readiness and the Road to IPO Panel from IPO Edge Bootcamp at Nasdaq
(IPO-Edge.com) |
May-09-24 03:09AM
|
Donnelley Financial Solutions Insider Sold Shares Worth $35,699,634, According to a Recent SEC Filing
(MT Newswires) |
May-07-24 02:24AM
|
Insider Sale at Donnelley Financial Solutions Inc (DFIN)
(GuruFocus.com) |
May-06-24 05:17PM
|
Donnelley Financial Solutions Insider Sold Shares Worth $1,213,390, According to a Recent SEC Filing
(MT Newswires) |
05:00PM
|
DFIN to Participate in Upcoming Investor Conferences
(PR Newswire) |
|
Donnelley Financial Solutions, Inc. engages in the provision of innovative software and technology-enabled financial regulatory and compliance solutions. It operates through the following segments: Capital Markets-Software Solutions (CM-SS), Capital Markets-Compliance and Communications Management (CM-CCM), Investment Companies-Software Solutions (IC-SS), Investment Companies-Compliance and Communications Management (IC-CCM), and Corporate. The CM-SS segment provides Venue and ActiveDisclosure to public and private companies to help manage public and private transactional and compliance processes, collaborate, and tag, validate, and file SEC documents. The CM-CCM segment offers tech-enabled services and print and distribution solutions to public and private companies for deal solutions and SEC compliance requirements. The IC-SS segment focuses on clients with the Arc Suite platform that contains a comprehensive suite of cloud-based solutions including ArcDigital, ArcReporting, ArcPro, and ArcRegulatory as well as services that enable storage and management of compliance and regulatory information. The IC-CCM segment is involved in turnkey proxy services including discovery, planning and implementation, print and mail management, solicitation, tabulation services, stockholder meeting review, and expert support. The Corporate segment includes unallocated selling, general, and administrative activities and associated expenses including executive, legal, finance, and certain facility costs. The company was founded on February 22, 2016 and is headquartered in Chicago, IL. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Jacobowitz Jeffrey | Director | May 14 '24 | Sale | 61.21 | 86,807 | 5,313,639 | 1,392,985 | May 16 07:35 PM | Jacobowitz Jeffrey | Director | May 13 '24 | Sale | 61.84 | 106,166 | 6,565,305 | 1,479,792 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 10 '24 | Sale | 61.94 | 53,812 | 3,333,156 | 1,585,958 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 09 '24 | Sale | 62.38 | 27,705 | 1,728,232 | 1,639,770 | May 13 08:01 PM | Jacobowitz Jeffrey | Director | May 08 '24 | Sale | 62.36 | 106,093 | 6,616,191 | 1,667,475 | May 08 08:26 PM |
|
|
|
|
Market Cap | 192.01B | EPS (ttm) | 7.35 |
P/E | 22.29 | EPS this Y | 30.99% |
Forward P/E | 14.64 | EPS next Y | 23.32% |
PEG | 0.88 | EPS past 5Y | 15.59% |
P/S | 2.45 | EPS next 5Y | 25.23% |
P/B | 3.11 | EPS Q/Q | 26.03% |
Dividend | 1.62% | Sales Q/Q | -0.19% |
Insider Own | 62.55% | Inst Own | 39.03% |
Insider Trans | -2.47% | Inst Trans | -1.05% |
Short Float | 5.53% | Earnings | Apr 25/a |
Analyst Recom | 1.50 | Target Price | 186.21 |
Avg Volume | 4.39M | 52W Range | 124.92 - 168.64 |
|
|
|
T-Mobile US, Inc. engages in the provision of wireless communications services under the T-Mobile and MetroPCS brands. It offers postpaid and prepaid wireless voice, messaging and data services, and wholesale wireless services. The company was founded in 1994 and is headquartered in Bellevue, WA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
DEUTSCHE TELEKOM AG | Director | May 16 '24 | Sale | 163.22 | 189,670 | 30,958,069 | 675,451,661 | May 16 07:34 PM | DEUTSCHE TELEKOM AG | Director | May 15 '24 | Sale | 162.93 | 189,670 | 30,903,506 | 675,641,331 | May 16 07:34 PM | DEUTSCHE TELEKOM AG | Director | May 14 '24 | Sale | 162.75 | 189,670 | 30,869,188 | 675,831,001 | May 14 06:40 PM | SIEVERT G MICHAEL | President and CEO | May 14 '24 | Sale | 162.84 | 20,000 | 3,256,800 | 438,124 | May 15 05:08 PM | DEUTSCHE TELEKOM AG | Director | May 13 '24 | Sale | 163.19 | 189,670 | 30,952,856 | 676,020,671 | May 14 06:40 PM |
|
|
| |
|
Market Cap | 2.53B | EPS (ttm) | -2.46 |
P/E | - | EPS this Y | -28.44% |
Forward P/E | 15.64 | EPS next Y | 37.52% |
PEG | - | EPS past 5Y | - |
P/S | 1.12 | EPS next 5Y | 16.00% |
P/B | 1.23 | EPS Q/Q | -298.83% |
Dividend | - | Sales Q/Q | -0.81% |
Insider Own | 12.85% | Inst Own | 92.92% |
Insider Trans | -35.64% | Inst Trans | -3.30% |
Short Float | 5.54% | Earnings | May 07/a |
Analyst Recom | 1.80 | Target Price | 136.00 |
Avg Volume | 249.83K | 52W Range | 78.28 - 196.88 |
|
|
|
ICU Medical, Inc. develops, manufactures, and sells innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
FINNEY ELISHA W | Director | May 16 '24 | Sale | 104.95 | 300 | 31,484 | 2,129 | May 16 07:30 PM | Hernandez Laurie | Director | May 15 '24 | Option Exercise | 0.00 | 948 | 0 | 1,885 | May 15 05:49 PM | Greenberg David C. | Director | May 15 '24 | Option Exercise | 0.00 | 948 | 0 | 5,037 | May 15 05:53 PM | FINNEY ELISHA W | Director | May 15 '24 | Option Exercise | 0.00 | 948 | 0 | 2,429 | May 15 06:06 PM | Abbey Donald | Director | May 15 '24 | Option Exercise | 0.00 | 948 | 0 | 3,027 | May 15 06:10 PM |
|
|
|
|
Market Cap | 1.08B | EPS (ttm) | -1.93 |
P/E | - | EPS this Y | -11.74% |
Forward P/E | - | EPS next Y | -21.10% |
PEG | - | EPS past 5Y | 5.16% |
P/S | - | EPS next 5Y | - |
P/B | 3.40 | EPS Q/Q | 32.00% |
Dividend | - | Sales Q/Q | - |
Insider Own | 45.90% | Inst Own | 57.30% |
Insider Trans | -7.55% | Inst Trans | -9.19% |
Short Float | 18.59% | Earnings | May 14/a |
Analyst Recom | 1.00 | Target Price | 34.67 |
Avg Volume | 307.49K | 52W Range | 9.80 - 26.00 |
|
|
|
Enliven Therapeutics, Inc. operates as a clinical stage precision oncology company. It is focused on the discovery and development of next-generation small molecule kinase inhibitors and advancing Enliven's pipeline of precision oncology product candidates. The company was founded by Sam S. Kintz, Joe P. Lyssikatos, and Anish Patel in June 2019 and is headquartered in Boulder, CO. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Patel Anish | CHIEF OPERATING OFFICER | May 14 '24 | Option Exercise | 2.48 | 1,107 | 2,745 | 1,107 | May 16 07:29 PM | Patel Anish | CHIEF OPERATING OFFICER | May 14 '24 | Sale | 25.00 | 1,107 | 27,675 | 0 | May 16 07:29 PM | Patel Anish | CHIEF OPERATING OFFICER | May 09 '24 | Option Exercise | 2.48 | 260 | 645 | 260 | May 13 07:35 PM | Patel Anish | CHIEF OPERATING OFFICER | May 09 '24 | Sale | 25.06 | 260 | 6,515 | 0 | May 13 07:35 PM | Patel Anish | CHIEF OPERATING OFFICER | May 06 '24 | Option Exercise | 2.48 | 4,875 | 12,090 | 4,875 | May 08 08:40 PM |
|
|
| |
|
Market Cap | 1.06B | EPS (ttm) | 2.40 |
P/E | 13.53 | EPS this Y | 13.61% |
Forward P/E | 4.76 | EPS next Y | 9.81% |
PEG | 24.60 | EPS past 5Y | - |
P/S | 1.87 | EPS next 5Y | 0.55% |
P/B | 4.78 | EPS Q/Q | 239.41% |
Dividend | - | Sales Q/Q | 0.11% |
Insider Own | 1.47% | Inst Own | 122.38% |
Insider Trans | -25.23% | Inst Trans | -1.94% |
Short Float | 21.28% | Earnings | May 09/a |
Analyst Recom | 2.33 | Target Price | 40.00 |
Avg Volume | 483.73K | 52W Range | 20.83 - 40.95 |
|
|
|
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients suffering from chronic pain and other diseases. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
BOHLIN GAREN G | Director | May 14 '24 | Option Exercise | 5.73 | 28,985 | 166,084 | 73,760 | May 16 07:20 PM | BOHLIN GAREN G | Director | May 14 '24 | Sale | 32.30 | 28,985 | 936,311 | 44,775 | May 16 07:20 PM | Smith Thomas B | EVP and Chief Medical Officer | Feb 29 '24 | Sale | 36.76 | 995 | 36,580 | 63,409 | Mar 04 04:26 PM | Dreyer Scott | EVP & Chief Commercial Officer | Feb 26 '24 | Sale | 36.43 | 10,000 | 364,270 | 138,918 | Feb 28 04:14 PM | Dreyer Scott | EVP & Chief Commercial Officer | Jan 16 '24 | Sale | 32.28 | 23,560 | 760,519 | 111,322 | Jan 18 04:19 PM |
|
|
|
|
Market Cap | 139.09B | EPS (ttm) | -3.45 |
P/E | - | EPS this Y | 118.77% |
Forward P/E | 15.94 | EPS next Y | 843.79% |
PEG | - | EPS past 5Y | - |
P/S | 7.60 | EPS next 5Y | -2.62% |
P/B | 3.17 | EPS Q/Q | 133.59% |
Dividend | 0.37% | Sales Q/Q | 57.70% |
Insider Own | 0.65% | Inst Own | 82.18% |
Insider Trans | -9.90% | Inst Trans | -1.27% |
Short Float | 2.42% | Earnings | Mar 20/a |
Analyst Recom | 1.49 | Target Price | 140.99 |
Avg Volume | 22.95M | 52W Range | 60.50 - 130.54 |
|
|
|
Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
MEHROTRA SANJAY | CEO and President | May 14 '24 | Option Exercise | 28.20 | 7,000 | 197,400 | 726,049 | May 16 07:03 PM | Bokan Michael W | SVP, Worldwide Sales | May 14 '24 | Sale | 123.42 | 15,000 | 1,851,300 | 138,387 | May 16 07:03 PM | MEHROTRA SANJAY | CEO and President | May 14 '24 | Sale | 122.89 | 7,000 | 860,209 | 719,049 | May 16 07:03 PM | Sadana Sumit | EVP and Chief Business Officer | May 13 '24 | Sale | 123.01 | 12,000 | 1,476,120 | 218,048 | May 13 07:07 PM | Sadana Sumit | EVP and Chief Business Officer | May 10 '24 | Option Exercise | 41.56 | 3,983 | 165,533 | 264,840 | May 13 07:07 PM |
|
|
| |
|
Market Cap | 83.90B | EPS (ttm) | 0.36 |
P/E | 950.44 | EPS this Y | 27.19% |
Forward P/E | 70.79 | EPS next Y | 24.00% |
PEG | 32.19 | EPS past 5Y | - |
P/S | 27.46 | EPS next 5Y | 29.52% |
P/B | 36.22 | EPS Q/Q | 207.23% |
Dividend | - | Sales Q/Q | 32.63% |
Insider Own | 7.26% | Inst Own | 68.05% |
Insider Trans | -3.58% | Inst Trans | 0.49% |
Short Float | 3.14% | Earnings | Jun 04/a |
Analyst Recom | 1.31 | Target Price | 398.03 |
Avg Volume | 3.49M | 52W Range | 133.61 - 365.00 |
|
|
|
CrowdStrike Holdings, Inc. provides cybersecurity products and services to stop breaches. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, Zero Trust identity protection, and log management. CrowdStrike serves customers worldwide. The company was founded by George P. Kurtz, Gregg Marston, and Dmitri Alperovitch on November 7, 2011, and is headquartered in Austin, TX. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Podbere Burt W. | CHIEF FINANCIAL OFFICER | May 15 '24 | Sale | 339.29 | 12,000 | 4,071,504 | 308,593 | May 16 07:00 PM | Henry Shawn | CHIEF SECURITY OFFICER | May 15 '24 | Sale | 333.52 | 4,000 | 1,334,075 | 204,961 | May 15 07:05 PM | Podbere Burt W. | CHIEF FINANCIAL OFFICER | May 14 '24 | Sale | 329.10 | 12,000 | 3,949,152 | 308,593 | May 16 07:00 PM | Kurtz George | PRESIDENT AND CEO | May 03 '24 | Sale | 304.41 | 56,279 | 17,132,096 | 1,146,048 | May 06 08:00 PM | Podbere Burt W. | CHIEF FINANCIAL OFFICER | May 03 '24 | Sale | 305.15 | 15,753 | 4,807,061 | 313,994 | May 06 08:00 PM |
|
|
|
|
Market Cap | 1.03B | EPS (ttm) | 1.67 |
P/E | 13.99 | EPS this Y | -10.99% |
Forward P/E | 11.20 | EPS next Y | 22.94% |
PEG | - | EPS past 5Y | - |
P/S | 0.75 | EPS next 5Y | - |
P/B | 1.39 | EPS Q/Q | 74.87% |
Dividend | - | Sales Q/Q | -0.59% |
Insider Own | 13.91% | Inst Own | 80.00% |
Insider Trans | -4.27% | Inst Trans | -2.87% |
Short Float | 6.86% | Earnings | May 09/a |
Analyst Recom | 3.00 | Target Price | 26.00 |
Avg Volume | 292.10K | 52W Range | 16.83 - 24.30 |
|
|
|
Metallus, Inc. engages in the manufacture of alloy, carbon and micro-alloy steel products. The firm's products include special bar quality steel, seamless mechanical tubing, gears, grades of steel, jumbo bloom vertical caster, TimkenSteel ultrapremium technology, and TimkenSteel endurance steels. Its services include thermal treatment, value added components, technical support and testing, supply chain, and TimkenSteel portal. The company was founded on October 24, 2013 and is headquartered in Canton, OH. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
Williams Michael S | President & CEO | May 16 '24 | Sale | 23.00 | 16,355 | 376,165 | 665,132 | May 16 07:00 PM | WESTBROOKS KRISTOPHER R | EVP, Chief Financial Officer | May 16 '24 | Sale | 23.00 | 3,321 | 76,383 | 177,921 | May 16 07:00 PM | Williams Michael S | President & CEO | May 15 '24 | Sale | 23.02 | 5,919 | 136,249 | 681,487 | May 15 07:00 PM | WESTBROOKS KRISTOPHER R | EVP, Chief Financial Officer | May 15 '24 | Sale | 23.02 | 2,310 | 53,181 | 181,242 | May 15 07:00 PM | Raketich Kevin A | EVP, Chief Commercial Officer | May 15 '24 | Sale | 23.00 | 1,000 | 23,000 | 82,551 | May 15 07:00 PM |
|
|
|
|
Market Cap | 13.64B | EPS (ttm) | 2.48 |
P/E | 46.97 | EPS this Y | -199.43% |
Forward P/E | - | EPS next Y | 62.93% |
PEG | - | EPS past 5Y | - |
P/S | 1.21 | EPS next 5Y | - |
P/B | 47.03 | EPS Q/Q | 115.30% |
Dividend | - | Sales Q/Q | 17.46% |
Insider Own | 16.96% | Inst Own | 94.93% |
Insider Trans | -6.49% | Inst Trans | 1.14% |
Short Float | 28.34% | Earnings | May 01/a |
Analyst Recom | 2.91 | Target Price | 105.19 |
Avg Volume | 6.21M | 52W Range | 10.20 - 129.00 |
|
|
|
Carvana Co. is a holding company and an eCommerce platform, which engages in the buying and selling of used cars. The company was founded by Ernest Garcia, III, Benjamin Huston and Ryan Keeton in 2012 and is headquartered in Tempe, AZ. |
Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
GARCIA ERNEST C. II | 10% Owner | May 15 '24 | Sale | 120.10 | 60,000 | 7,205,838 | 2,497,500 | May 16 06:50 PM | GARCIA ERNEST C. II | 10% Owner | May 14 '24 | Sale | 120.26 | 60,000 | 7,215,590 | 2,557,500 | May 16 06:50 PM | GARCIA ERNEST C. II | 10% Owner | May 13 '24 | Sale | 119.27 | 60,000 | 7,156,031 | 2,617,500 | May 14 05:26 PM | GARCIA ERNEST C. II | 10% Owner | May 10 '24 | Sale | 116.78 | 54,908 | 6,412,291 | 2,677,500 | May 14 05:26 PM | GARCIA ERNEST C. II | 10% Owner | May 09 '24 | Sale | 116.68 | 60,000 | 7,000,771 | 2,737,500 | May 10 06:38 PM |
|
|
|